Literature DB >> 7691641

A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice.

A Sureda1, A Valls, E Kadar, M Algara, J Inglés-Esteve, A Bigas, M Jaume, M Lacruz, L M Tobajas, M Rutllant.   

Abstract

Granulocyte colony stimulating factor (G-CSF) stimulates the proliferation of progenitor cells committed to myeloid differentiation. In animal models, G-CSF is able to stimulate granulocyte recovery and promote survival after lethal or sublethal irradiation when administered as daily injections, suggesting an influence on the residual hematopoietic primitive precursors surviving irradiation. In this study, we clearly demonstrate that a single dose of G-CSF (1 mg/kg) administered to B6D2F1 mice 2 hours after a lethal dose 95/30 irradiation achieves a 78% survival at day +30 after irradiation. Survival of G-CSF treated mice compares favourably with that of syngenic bone marrow transplantation recipients (78% vs 90%, ns).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691641

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice.

Authors:  A M Buisman; T L Van Zwet; J A Langermans; M F Geertsma; P J Leenen; R van Furth
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different Radiosensitivity.

Authors:  Merriline Satyamitra; Vidya P Kumar; Shukla Biswas; Lynnette Cary; Leonora Dickson; Srinivasan Venkataraman; Sanchita P Ghosh
Journal:  Radiat Res       Date:  2017-03-31       Impact factor: 2.841

3.  PEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.

Authors:  Paul Artur Plett; Hui Lin Chua; Carol H Sampson; Barry P Katz; Christine M Fam; Lana J Anderson; George N Cox; Christie M Orschell
Journal:  Health Phys       Date:  2014-01       Impact factor: 1.316

Review 4.  The impact of the myeloid response to radiation therapy.

Authors:  Michael J Gough; Kristina Young; Marka Crittenden
Journal:  Clin Dev Immunol       Date:  2013-04-07

5.  Human ghrelin mitigates intestinal injury and mortality after whole body irradiation in rats.

Authors:  Zhimin Wang; Weng Lang Yang; Asha Jacob; Monowar Aziz; Ping Wang
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

Review 6.  Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.

Authors:  Vijay K Singh; Patricia L P Romaine; Victoria L Newman; Thomas M Seed
Journal:  Expert Opin Ther Pat       Date:  2016-09-09       Impact factor: 6.674

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.